Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Terranueva Corporation (TEQ) has closed a non-brokered private placement of second rank convertible debentures for gross proceeds of $2,950,000
  • The principal amount and five per cent annual interest are payable in five years, maturing on July 12, 2027
  • The proceeds will be used primarily to replenish the corporation’s working capital and for business development
  • Terranueva is leveraging research and development to become a major player in the emerging cannabis industry
  • Terranueva (TEQ) is unchanged on the day, trading at C$0.05 per share at 4:15 pm ET

Terranueva (TEQ) has closed a non-brokered private placement of second rank convertible debentures for gross proceeds of $2,950,000.

The debentures bear an annual interest rate of 5 per cent. The principal amount and interest are payable in five years, maturing on July 12, 2027. The principal amount is convertible at any time until July 13, 2025 into voting common shares of Terranueva at a conversion price of $0.08 per share.

The debentures and the underlying common shares are subject to a mandatory four-month holding period.

The proceeds will be used primarily to replenish the corporation’s working capital and for business development.

Terranueva is leveraging research and development to become a major player in the emerging cannabis industry.

Terranueva (TEQ) is unchanged on the day, trading at C$0.05 per share at 4:15 pm ET.

More From The Market Herald

" Christina Lake Cannabis (CSE:CLC) recaps Q2 results

Christina Lake Cannabis (CLC) recap its second quarter financial results for the six-month period ended May 31, 2022.

" Aleafia Health (TSX:AH) earns record quarter-over-quarter revenue in Q1 2023

Aleafia Health (AH) reported its financial results for the three months ended June 30, 2022.
InnoCan - Founder and CEO, Iris Bincovich.

" Innocan Pharma (CSE:INNO) approaches 100 per cent CBD bioavailability for its LPT CBD liposomal delivery platform

Innocan Pharma (INNO) has announced results from a clinical study on dogs suffering from pain.

" Bhang (CSE:BHNG) President/CEO and Director stepping down

Bhang’s (BHNG) President/CEO and Director Jamie Pearson is stepping down after seven years with the company.